Simplifying Global Compliance
High Court Ruling Favors Disclosure Of Adverse Events From Companies
Washington Drug Letter
The U.S. Supreme Court ruled in a unanimous decision that drug companies must report adverse events to shareholders even though they may not be statistically significant.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing